Imperial College London
Clinical trials sponsored by Imperial College London, explained in plain language.
-
Liver cancer treatment trial stops early — only 4 patients tested
Disease control TerminatedThis early-phase trial tested a device called QuiremSpheres® — tiny radioactive beads — in people with liver cancer that couldn't be surgically removed. The goal was to see if the treatment was safe and could shrink tumors. However, the study was terminated early and only enrolle…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 24, 2026 11:08 UTC
-
Promising cancer drug trial halted after just one patient
Disease control TerminatedThis study aimed to see if giving Lutathera (a radioactive drug) after surgery to remove liver metastases from neuroendocrine tumors could help keep the cancer from coming back. It planned to compare Lutathera plus best supportive care against best supportive care alone in about …
Phase: PHASE2 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 22, 2026 12:00 UTC
-
Smart insulin pump system tested for type 1 diabetes – study ends early
Disease control TerminatedThis study tested whether an automated insulin delivery system could help adults with type 1 diabetes manage their blood sugar levels. The system combined a continuous glucose monitor, an insulin pump, and a smart algorithm to adjust insulin automatically. Only one person took pa…
Phase: NA • Sponsor: Imperial College London • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
Heart rhythm study seeks to predict ablation success
Knowledge-focused TerminatedThis study looked at a common heart rhythm problem called atrial fibrillation (AF). The goal was to find better ways to predict which patients would benefit from a procedure called ablation, which creates scar tissue in the heart to stop abnormal rhythms. Researchers planned to u…
Sponsor: Imperial College London • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:09 UTC